Dutch Study Reveals Real-World Olaparib Outcomes and Genomic Testing Gaps
A nationwide Dutch registry study shows real-world olaparib therapy achieved a 13.4-month median overall survival in BRCA-mutated prostate cancer, with ...
A nationwide Dutch registry study shows real-world olaparib therapy achieved a 13.4-month median overall survival in BRCA-mutated prostate cancer, with ...
A Moroccan cohort study of 215 advanced ovarian cancer patients found local HRD testing feasible, with 55.1 percent of evaluable ...
A multi-omics study combining genomics and spatial transcriptomics finds that BRCA-mutated high-grade serous ovarian cancers show stronger interferon and inflammatory ...
In a groundbreaking retrospective cohort study published in The Lancet Oncology, researchers at the University of Cambridge have delivered compelling ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.